Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
Key facts
- Who runs it
- University of Illinois Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 3,000 people, planned
- Started
- 28 Jan 2025
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mi Quit Care
- Record updated
- 30 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- aged 18 years and older
- current smoker
- English speaking
- Patient at Mile Square Health Center (Main, Englewood, South Shore, Auburn Gresham, Cicero, Back of the Yards)
Who cannot take part
- aged less than 18
- non-smoker
- non English speaking
- Not a patient at MSHC
Where in United States
- University of Illinois at ChicagoChicago, United States
About the trial
What the trial wants to find out
The over-arching research question is: Does message (Advise) and referral approach (Refer) influence a patient's willingness to "opt-in" to receive a call from an Illinois Tobacco Quitline (ITQL) smoking cessation coach in patients at MSHC.
Read full original descriptionShow less
Primary UH3 study aim: Compare the effect of the portal-delivered Choice message (Arm 1) to the Information-only message (Arm 3) on linkage to the Illinois Tobacco Quitline (i.e., spoke to a Quitline coach).
Secondary UH3 aims are to:
Examine the reach of the patient portal for delivering "Advise" and "Refer" at 4 weeks. Reach is defined as a patient opening the portal-delivered provider message across all three Arms.
Compare the effect of the Quit message (Quit, Arm 2) to Information-only (Arm 3) on linkage to ITQL.
Compare the effect of the Facilitated-referral messages (opt-in link in the message: Arm 1 \& 2) vs. Self-referral (Information-only, Arm 3) on linkage to the ITQL (speaking to an ITQL coach) at four weeks.
Compare the effect of the portal-message content of the Choice message (Arm 1) vs. the Quit message (Arm 2) on linkage acceptance (opting in to be called by the ITQL) at 4 weeks.
Compare the effectiveness of re-engagement message 1 to message 2 for linkage to the ITQL among patients who opted-in to an ITQL call but who were not reached after 3 attempts.
Evaluate the cost-effectiveness of using a patient portal to advise patients to change their smoking behavior and refer them to the ITQL. We will compare the costs associated with our project to the costs associated with advising and referring patients during clinical appointments.
The 2 groups in the trial
- MiQuit CareTreatment being tested
Intervention arm: Advise to quit + automatic linkage to quitline + patient navigation
Treatment: Mi Quit Care
- Enhanced Standard of CareExisting treatment, for comparison
Active Comparator: Advise to quit + written self-help materials
Treatment: Mi Quit Care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- A Study Protocol for Increasing Access to Smoking Cessation Treatments for Low-Income Minority Smokers.Frontiers in public health, 2021
- Record updated
- 30 March 2026